Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 4;12(12):1951.
doi: 10.3390/genes12121951.

NGS Evaluation of a Bernese Cohort of Unexplained Erythrocytosis Patients

Affiliations

NGS Evaluation of a Bernese Cohort of Unexplained Erythrocytosis Patients

Katarzyna Aleksandra Jalowiec et al. Genes (Basel). .

Abstract

(1) Background: Clinical and molecular data on patients with unexplained erythrocyto-sis is sparse. We aimed to analyze the clinical and molecular features of patients with congenital erythrocytosis in our tertiary reference center. (2) Methods: In 34 patients with unexplained erythrocytosis, a 13-gene Next-Generation Sequencing erythrocytosis panel developed at our center was conducted. (3) Results: In 6/34 (18%) patients, eight different heterozygous gene variants were found. These patients were, therefore, diagnosed with congenital erythrocytosis. Two patients had two different gene variants each. All variants were characterized as variants of unknown significance as they had not previously been described in the literature. The rest of the patients (28/34, 82%) had no detected gene variants. (4) Conclusions: Our experience shows that the NGS panel can be helpful in determining the reasons for persistent, unexplained erythrocytosis. In our cohort of patients with erythrocytosis, we identified some, thus far unknown, gene variants which may explain the clinical picture. However, further investigations are needed to determine the relationship between the molecular findings and the phenotype.

Keywords: NGS; erythrocytosis; polycythemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

    1. Camps C., Petousi N., Bento C., Cario H., Copley R.R., McMullin M.F., van Wijk R., Ratcliffe P.J., Robbins P.A., Taylor J.C., et al. Gene Panel Sequencing Improves the Diagnostic Work-up of Patients with Idiopathic Erythrocytosis and Identifies New Mutations. Haematologica. 2016;101:1306–1318. doi: 10.3324/haematol.2016.144063. - DOI - PMC - PubMed
    1. Bento C. Genetic Basis of Congenital Erythrocytosis. Int. J. Lab. Hematol. 2018;40:62–67. doi: 10.1111/ijlh.12828. - DOI - PubMed
    1. Patnaik M.M., Tefferi A. The Complete Evaluation of Erythrocytosis: Congenital and Acquired. Leukemia. 2009;23:834–844. doi: 10.1038/leu.2009.54. - DOI - PubMed
    1. Prchal J.F., Axelrad A.A. Letter: Bone-Marrow Responses in Polycythemia Vera. N. Engl. J. Med. 1974;290:1382. doi: 10.1056/nejm197406132902419. - DOI - PubMed
    1. Levine R.L., Wadleigh M., Cools J., Ebert B.L., Wernig G., Huntly B.J.P., Boggon T.J., Wlodarska I., Clark J.J., Moore S., et al. Activating Mutation in the Tyrosine Kinase JAK2 in Polycythemia Vera, Essential Thrombocythemia, and Myeloid Metaplasia with Myelofibrosis. Cancer Cell. 2005;7:387–397. doi: 10.1016/j.ccr.2005.03.023. - DOI - PubMed

Publication types

LinkOut - more resources